With over 40 years’ experience in vaccine science, immunology, and pharmaceutical development. Dr. Young served as the Novavax Board of Directors Chairman from 2011- 3/25. Prior to Novavax, he served as President of Research and Development at MedImmune. He played a key role in the Operation Warp Speed effort while at Novavax.
Dr. Young received his PhD from Baylor College of Medicine and a postdoctoral fellowship at Mt. Sinai School of Medicine in New York.